Article info
PDFRecommendation
The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation
- Correspondence to Professor Monika Østensen, National Service for Pregnancy and Rheumatic Diseases, Department of Rheumatology, Trondheim University Hospital, Trondheim 7006, Norway; monika.ostensen{at}gmail.com
Citation
The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation
Publication history
- Received October 30, 2015
- Revised December 21, 2015
- Accepted January 22, 2016
- First published February 17, 2016.
Online issue publication
October 25, 2017
Article Versions
- Previous version (25 October 2017).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
- Data supplement 1 - Online figure
- Data supplement 2 - Online table S1
- Data supplement 3 - Online table S2
- Data supplement 4 - Online table S3
- Data supplement 5 - Online table S4
- Data supplement 6 - Online table S5
- Data supplement 7 - Online table S6
- Data supplement 8 - Online table S7
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/